EVEREST MEDICINES LIMITED

Transcripts Everest Medicines Limited

Equities

1952

KYG3224E1061

Market Closed - Hong Kong S.E. Other stock markets 01:38:11 08/05/2024 pm IST			5-day change	1st Jan Change
24.05 ^HKD	0.00%		-1.64%	+15.07%

02:05am	Everest Medicines Announces New Drug Application Approval of Velsipity® for Adults with Moderately to Severely Active Ulcerative Colitis in Macau	CI
02/05	Everest Medicines Announces Hong Kong Department of Health Approval of Nefecon® for the Treatment for Primary IgA Nephropathy in Adult Patients	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Everest Medicines Limited, 2023 Earnings Call, Mar 27, 2024	28/03
Transcript : Everest Medicines Limited - Special Call	27/11
Transcript : Everest Medicines Limited, H1 2023 Earnings Call, Aug 24, 2023	24/23/24
Transcript : Everest Medicines Limited, 2022 Earnings Call, Mar 30, 2023	31/23/31
Transcript : Everest Medicines Limited - Special Call	03/23/03
Transcript : Calliditas Therapeutics AB, Everest Medicines Limited - Special Call	14/22/14
Transcript : Everest Medicines Limited - Special Call	16/22/16
Transcript : Everest Medicines Limited, 2021 Earnings Call, Mar 29, 2022	29/22/29
Transcript : Everest Medicines Limited, H1 2021 Earnings Call, Aug 30, 2021	31/21/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW